Knowledge about COPD among users of primary health care services

Queiroz, Maria de Castro Antonelli Monteiro de Conceição; Moreira, Maria Auxiliadora Carmo; Jardim, José Roberto; Barbosa, María Alves; Minamisava, Ruth; Gondim, Heicilainy Del Carlos; Velasco, Flávia Castro; Penhavel, Maria Victoria Carmo

doi:10.2147/copd.s71152

Cited by 12 publications

(12 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The questions included on the survey were selected based on previous papers published about knowledge surveys 5 , 9 , 13 and based on the research team’s experience and knowledge about the disease ( Supplementary material ). The format of the questions differed according to the objective of each item.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Understanding of COPD among final-year medical students

Mohigefer¹,

Calero-Acuña

Márquez-Martín

et al. 2017

COPD

View full text Add to dashboard Cite

ObjectiveSeveral previous studies have shown a suboptimal level of understanding of COPD among different population groups. Students in their final year of Medicine constitute a population that has yet to be explored. The evaluation of their understanding provides an opportunity to establish strategies to improve teaching processes. The objective of the present study is to determine the current level of understanding of COPD among said population.MethodsA cross-sectional observational study was done using digital surveys given to medical students in their final year at the Universidad de Sevilla. Those surveyed were asked about demographic data, smoking habits as well as the clinical manifestation, diagnosis and treatment of COPD.ResultsOf the 338 students contacted, responses were collected from 211 of them (62.4%). Only 25.2% had an accurate idea about the concept of the disease. The study found that 24.0% of students were familiar with the three main symptoms of COPD. Tobacco use was not considered a main risk factor for COPD by 1.5% of students. Of those surveyed, 22.8% did not know how to spirometrically diagnose COPD. Inhaled corticosteroids were believed to be part of the main treatment for this disease among 51.0% of the students. Results show that 36.4% of respondents believed that home oxygen therapy does not help COPD patients live longer. Only 15.0% considered the Body-mass index, airflow Obstruction, Dyspnea, and Exercise (BODE) index to be an important parameter for measuring the severity of COPD. Giving up smoking was not believed to prevent worsening COPD among 3.4% of students surveyed. Almost half of students (47.1%) did not recommend that those suffering from COPD undertake exercise.ConclusionThe moderate level of understanding among the population of medical students in their final year shows some strengths and some shortcomings. Teaching intervention is required to reinforce solid knowledge among this population.

show abstract

Section: Methodsmentioning

confidence: 99%

“…Unfortunately, the available evidence suggests that the lack of knowledge about the disease is high among a variety of populations. Studies have been done among patients with varying conditions, 5 among patients with COPD, 6 , 7 among doctors 8 and among the general population, 9 demonstrating suboptimal knowledge about COPD.…”

Section: Introductionmentioning

confidence: 99%

Understanding of COPD among final-year medical students

Mohigefer¹,

Calero-Acuña

Márquez-Martín

et al. 2017

COPD

View full text Add to dashboard Cite

show abstract

“…In Spain, an improvement was observed between two different surveys done in 2002 and 2011, but still the knowledge of the term COPD was barely 17.0%. This phenomenon has also been described in Brazil, Poland and Korea . The key issue here is that these patients would not go for a doctor evaluation if they do not know about the symptoms or warning signs.…”

Section: Disability‐adjusted Life Year (Daly)mentioning

confidence: 99%

Global burden of COPD

2015

View full text Add to dashboard Cite

It is estimated that the world population will reach a record 7.3 billion in 2015, and the high burden of chronic conditions associated with ageing and smoking will increase further. Respiratory diseases in general receive little attention and funding in comparison with other major causes of global morbidity and mortality.In particular, chronic obstructive pulmonary disease (COPD) has been a major public health problem and will remain a challenge for clinicians within the 21st century. Worldwide, COPD is in the spotlight, since its high prevalence, morbidity and mortality create formidable challenges for health-care systems. This review emphasizes the magnitude of the COPD problem from a clinician's standpoint by drawing extensively from the new findings of the Global Burden of Disease study. Updated,distilled information on the population distribution of COPD is useful for the clinician to help provide an appreciation of the relative impact of COPD in daily practice compared with other chronic conditions, and to allocate minimum resources in anticipation of future needs in care. Despite recent trends in reduction of COPD standardized mortality rates and some recent successes in anti-smoking efforts in a number of Western countries, the overarching demographic impact of ageing in an ever-expanding world population, joined with other factors such as high rates of smoking and air pollution in Asia, will ensure that COPD will continue to pose an ever-increasing problem well into the 21st century.

show abstract

“…Owing to the lack of awareness about the high prevalence of COPD among both doctors and patients, underdiagnosis is a severe problem. 3 – 6 Many patients are diagnosed in the moderate-to-severe stage and even in the very severe stage, when they come to the hospital for help with respiratory symptoms. Patients with high-grade COPD impose a high economic burden on the health care system.…”

Section: Introductionmentioning

confidence: 99%

Risk factors for FEV<sub>1</sub> decline in mild COPD and high-risk populations

Chen

Wang²,

Li³

et al. 2017

COPD

View full text Add to dashboard Cite

BackgroundEarly diagnosis of COPD is often not achieved due to limited recognition and limited access to the pulmonary function test. Our hypothesis was that lung function decline may be different between populations with mild COPD and those who are at high risk and do not receive treatment.Patients and methodsSubjects with mild COPD and those from a high-risk COPD population were recruited from a community-based COPD epidemiological study after obtaining consent. Baseline clinical characteristics, symptom questionnaire, spirometry, low-dose computed tomography (LDCT) chest scan, and blood plasma biomarker data were collected initially and then 1 year later.ResultsA total of 617 participants were recruited, and 438 eventually completed the first-year follow-up visit; 72 participants (46 males) were in the mild COPD group, and 225 participants (165 males) were in the high-risk group. The mean forced expiratory volume in the first second of expiration (FEV1) decline in the mild COPD group was 129 mL, which was significantly higher than the 30 mL decline in the high-risk population group (P=0.005). Group category (odds ratio [OR] =0.230) and COPD Assessment Test (CAT) score (OR =9.912) were independent risk factors for an FEV1% predicted decline of >15% for all participants. In the mild COPD group, patients with a higher CAT (OR =5.310) and Emphysema Index (OR =5.681) were associated with a FEV1% predicted decline of >15% at the first-year follow-up. No factor showed a significantly predictive effect on FEV1 decline in the high-risk COPD group.ConclusionGroup category was an independent influential factor associated with FEV1 decline.

show abstract

Knowledge about COPD among users of primary health care services

Cited by 12 publications

References 14 publications

Understanding of COPD among final-year medical students

Understanding of COPD among final-year medical students

Global burden of COPD

Risk factors for FEV<sub>1</sub> decline in mild COPD and high-risk populations

Contact Info

Product

Resources

About